Breaking Barriers in Neuraxial Ultrasound Adoption

Breaking Barriers in Neuraxial Ultrasound Adoption

Reimbursement gaps and inconsistent complication reporting might be slowing the adoption of neuraxial ultrasound. Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — explains why these systemic challenges must be addressed to ensure advanced ultrasound...
Spinal Needle Guidance for Value-Based Care

Spinal Needle Guidance for Value-Based Care

Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — discusses the future of spinal needle guidance in a healthcare system still dominated by fee-for-service models. As the industry moves toward value-based care, RIVANNA is leading the way with...
The Future of Neuraxial Anesthesia

The Future of Neuraxial Anesthesia

This content was reviewed and updated in 2025 to reflect current clinical evidence and recent guidelines. Anesthesiology is in flux. Particularly in the United States, demographics, economics, and technology are driving changes to care delivery mechanisms from the...
AI-Assisted Neuraxial Anesthesia: Safety Meets Efficiency

AI-Assisted Neuraxial Anesthesia: Safety Meets Efficiency

The convergence of AI-guided neuraxial anesthesia and ultrasound-assisted anesthesia marks a profound shift in how we administer, teach, and measure the success of anesthesia procedures. With real-time data processing, image enhancement, and automated guidance, AI has...